Check Immunoglobulin Levels
In a 35-year-old non-smoking man with bronchiectasis and recurrent sinusitis and pneumonia, the next best step is to check immunoglobulin levels (option C), as this clinical presentation strongly suggests primary immunodeficiency, particularly common variable immunodeficiency (CVID). 1, 2
Rationale for Immunoglobulin Testing
This patient's presentation is classic for antibody deficiency:
- Young age (35 years) with bronchiectasis in a non-smoker
- Recurrent sinopulmonary infections (sinusitis AND pneumonia)
- No emphysema or fibrosis (making alpha-1 antitrypsin deficiency less likely)
The 2025 European Respiratory Society guidelines explicitly recommend testing for underlying causes in bronchiectasis, with immunodeficiency being a key treatable etiology 1. The 2015 immunodeficiency practice parameter confirms that CVID typically presents with recurrent bacterial respiratory infections including sinusitis, bronchitis, and pneumonia 2. Recent evidence emphasizes that recurrent infections with unexplained bronchiectasis should prompt evaluation for primary immunodeficiency 3.
Initial Immunologic Workup
The appropriate initial testing includes:
- Serum IgG, IgA, IgM, and IgE levels 2, 4
- Functional antibody testing (IgG antibodies to tetanus/diphtheria and pneumococcal antibodies) should follow if immunoglobulin levels are abnormal or if clinical suspicion remains high despite normal levels 2
Why Not the Other Options?
Alpha-1 Antitrypsin Deficiency (Option A)
- Typically presents with emphysema (particularly basilar), which this patient explicitly does not have 1
- The 2025 ERS guidelines recommend limiting alpha-1 antitrypsin testing to patients with suggestive clinical features 1
- This patient's lack of emphysema makes this diagnosis unlikely
ANCA Antibodies (Option B)
- Would be appropriate if there were features suggesting vasculitis or autoimmune disease
- Not the first-line test in isolated recurrent sinopulmonary infections
IgG Antibodies to Tetanus/Diphtheria (Option D)
- This is functional antibody testing, which is part of the immunodeficiency workup
- However, it should be performed after measuring baseline immunoglobulin levels 2
- If immunoglobulins are low, functional testing helps confirm the diagnosis
- If immunoglobulins are normal but clinical suspicion is high, functional testing can identify specific antibody deficiency
Clinical Significance
Approximately 13-25% of CVID patients develop bronchiectasis 5, and this complication is associated with:
- Lower serum IgA levels
- Chronic rhinosinusitis and recurrent pneumonia
- Progressive lung function decline
Early recognition and initiation of immunoglobulin replacement therapy can improve outcomes 3. The 2025 ERS guidelines emphasize that identifying treatable aetiologies like immunodeficiency is essential because specific treatments are available 1.
Important Caveat
If initial immunoglobulin levels are normal but clinical suspicion remains high (recurrent infections, bronchiectasis in a young non-smoker), referral to an immunologist should be considered for more detailed evaluation including functional antibody testing and assessment for other immunodeficiency syndromes 1, 2.
budget:budget_used